Associate Professor of Pathology, Johns Hopkins University School of Medicine; Program Director, Renal Pathology Fellowship Training Program
Pathology
Dr. Lois J. Arend, MD
|
|
Give Review
Lois J. Arend practices Pathology. Lois J. Arend is a published MD. She published 23 publications, including: 'Crystal-storing histiocytosis.'
Publications
- Crystal-storing histiocytosis.
- Late antibody-mediated rejection in renal allografts: outcome after conventional and novel therapies.
- Novel roles of Pkd2 in male reproductive system development.
- Proliferation Patterns in a Pig Model of AV Fistula Stenosis: Can we Translate Biology into Novel Therapies?
- Natural history of venous morphologic changes in dialysis access stenosis.
- Pathogenetic role for early focal macrophage infiltration in a pig model of arteriovenous fistula (AVF) stenosis.
- Pkd1 is required for male reproductive tract development.
- Incidence and Outcomes of BK Virus Allograft Nephropathy among ABO- and HLA-Incompatible Kidney Transplant Recipients.
- Deletion of the pH sensor GPR4 decreases renal acid excretion.
- Proteasome inhibitor-based primary therapy for antibody-mediated renal allograft rejection.
- Deletion of the chloride transporter slc26a7 causes distal renal tubular acidosis and impairs gastric acid secretion.
- Reducing de novo donor-specific antibody levels during acute rejection diminishes renal allograft loss.
- Spermidine/spermine-N1-acetyltransferase ablation protects against liver and kidney ischemia-reperfusion injury in mice.
- Dynamic regulation of sphingosine-1-phosphate homeostasis during development of mouse metanephric kidney.
- Emerging therapy-related kidney disease.
- Bortezomib provides effective therapy for antibody- and cell-mediated acute rejection.
- Hemodynamic wall shear stress profiles influence the magnitude and pattern of stenosis in a pig AV fistula.
- Vascular dysfunction in S1P2 sphingosine 1-phosphate receptor knockout mice.
- B cell depletion as a novel treatment for systemic lupus erythematosus: a phase I/II dose-escalation trial of rituximab.
- Smac3, a novel Smac/DIABLO splicing variant, attenuates the stability and apoptosis-inhibiting activity of X-linked inhibitor of apoptosis protein.
- A rare complication of monoclonal gammopathy.
- Sarcoidosis in native and transplanted kidneys: incidence, pathologic findings, and clinical course.
Schools
Michigan State University
Doctors Specialties
- Anatomic Pathology
- Pathology
Accepted Insurances
Education
-
University of Michigan Hospitals and Health Centers -
Michigan State University College of Human Medicine
Hospital
-
Johns Hopkins Bayview Medical Center -
Johns Hopkins Hospital
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1134149578 |
| Last Name Of The Provider | AREND |
| First Name Of The Provider | LOIS |
| View All |
Similar Doctors
|
|
Dr. Beatriz H. Porras, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Daniel R. Beckman, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Hai X. Bui, MD |
|
|
Dr. Gregory G. Boren, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Honora H. Favorito, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Pamela B. Sequeira, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Kathryn Wikenheiser-Brokamp, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Richard L. McMasters, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Toni M. Robinson-Smith, MD |
|
|
Dr. Mark A. Weiss, MD |
|
|
Dr. Baojin Fu, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Anne M. Laib, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Jiang Wang, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Rachel M. Sheridan, MD
This Doctor is OpenDoctor Recommended.
|